News & Publications

May 9, 2020

The Facts About COVID-19: A Conversation [in Farsi] about COVID-19, Facts, Myths, and Your Health

On Saturday, May 9th, NIAC was thrilled to host a very special medical panel on COVID-19 pandemic and the critical things you need to know. The aim of this panel was to distill the facts and truth about COVID-19 from the harmful myths and misinformation. Joined by Drs. Kamran Tabaddor, Javad Aman, Ashkan Emadi, and Farin Kamandar, the discussion included topics on how the virus is transmitted, its symptoms, how you can protect yourself and your loved ones, and what you should do if you display symptoms.

You can watch the entire discussion in Persian (Farsi) below:

Learn more about these expert doctors:

Ashkan Emadi, MD, PhD is a medical doctor and a chemist, and currently serves as a Professor of Medicine and Pharmacology at the University of Maryland School of Medicine. Dr. Emadi has had a wide range of experience in developing, testing, and approving drugs. As an organic chemist, Dr. Emadi synthesized new molecules that can be used as anti-neoplastic and anti-HIV compounds. As a physician-scientist, Dr. Emadi regularly sees patients and supervises clinical research projects at the University of Maryland Greenebaum Comprehensive Cancer Center. As a former FDA officer, he has been responsible for approving new drugs. When it comes to drugs, he has seen it all.

Dr. Emadi is the principal investigator of a clinical trial entitled “Randomized Double-Blind Placebo-Controlled Trial on the Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19”.

Javad Aman, PhD, has over 30 years of experience in the fields of immunology, microbiology and vaccine development. A highly accomplished scientist, Dr. Aman has published over 100 scientific articles, including many in highly prestigious journals, such as Cell, Science, and Proceeding of the National Academy of Sciences.

Dr. Aman has made important discoveries, such as the receptor for human interleukin-13 as well as small molecule inhibitors and monoclonal antibodies for Ebola and Marburg viruses. In 2007, he founded the research-based company Integrated Biotherapeutics (IBT), where he and his staff develop vaccines and antibody therapeutics for emerging infectious disease. The company has thus far received nearly $80 million of research funding from the US government and prestigious funding agencies.

Farin Kamangar, MD, PhD, is a physician scientist with expertise in the field of epidemiology. Dr. Kamangar is currently a University Distinguished Professor and Associate Dean for Research at Morgan State University, Baltimore.

Dr. Kamangar is an accomplished scientist who has authored over 200 publications, including papers in highly prestigious medical journal, such as the Lancet, the Lancet Oncology, and British Medical Journal (BMJ). He has been the principal investigator or co-principal investigator of nearly $60 million in grant funding, and works closely with scientists from the US National Institutes of Health, World Health Organization, and Tehran University. He has received over 20 awards and honors for his research, teaching and service.

Back to top